Brief: Dyadic Announces Research And Development Collaboration Agreement With Global Biopharmaceutical Company
06/02/2024 14:27
Feb 6 (Reuters) - Dyadic International Inc DYAI.O :
* DYADIC ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION
AGREEMENT WITH GLOBAL BIOPHARMACEUTICAL COMPANY
* DYADIC INTERNATIONAL INC - UNDER AGREEMENT, RESEARCH AND
DEVELOPMENT ACTIVITIES WILL BE FUNDED BY GLOBAL
BIOPHARMACEUTICAL COMPANY
Source text for Eikon: ID:nGNX7Yy5bJ
Further company coverage: DYAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dyadic International
See all newsDyadic International Inc reports results for the quarter ended June 30 - Earnings Summary
Dyadic International Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Dyadic International - Develops C1 Cell Lines And Manufactures Bundibugyo Ebolavirus Antigens Within 15 Days
Brief: Dyadic Announces Continued Listing On The Nasdaq Capital Market
Brief: Dyadic And Scripps Research Collaborate On Rapid-Response Hantavirus Antibody And Vaccine Development